Pancreatic digestive enzymes (Pancreatic lipase, amylase, and proteases)

Pancreatic digestive enzymes, including pancreatic lipase, alpha-amylase, and various proteases (such as trypsin and chymotrypsin), are essential for the breakdown of dietary macronutrients into absorbable units within the small intestine [1]. Pancreatic lipase hydrolyzes dietary fats into fatty acids and monoglycerides, alpha-amylase breaks down complex carbohydrates into simple sugars, and proteases cleave proteins into peptides and amino acids [2, 3]. These enzymes are primary therapeutic targets in conditions like exocrine pancreatic insufficiency (EPI), where replacement therapy (pancrelipase) is used to restore digestive function and prevent malnutrition [5]. Conversely, specific enzymes like pancreatic lipase are targeted for inhibition by drugs such as orlistat to reduce caloric intake and treat obesity [4]. Modulation of these enzymes is also relevant in managing metabolic disorders like type 2 diabetes through the slowing of carbohydrate absorption via amylase inhibition [1].

Other names

PancrelipasePancreatinPancreatic enzymesDigestive hydrolasesDietary macronutrient substrates via pancreatic lipase, amylase, and proteases

Inhibition of pancreatic lipase to prevent the hydrolysis of dietary triglycerides into absorbable free fatty acids; competitive inhibition of alpha-amylase to slow the breakdown of complex carbohydrates; and exogenous replacement of lipase, amylase, and proteases to restore digestive capacity in enzyme-deficient states [1, 4, 5].